Siren Biotechnology, Catalent Partner for Manufacturing of AAV Gene Therapies
Breaking News Catalent to support the development and manufacturing of Siren Biotechnology’s AAV immuno-gene therapies for cancer. 05.17.24 Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for Cancer, and Catalent Inc., which was recently …